Alight Inc

Alight Inc (ALIT) Stock Analysis

$14.020

-0.188 (-1.34%)At close

Loading chart…
High
14.795
Open
14.210
VWAP
14.28
Vol
407.94K
Mkt Cap
3.91B
Low
14.020
Amount
5.82M
EV/EBITDA, TTM
7.40

Alight, Inc. is a cloud-based human capital technology and services provider. It is engaged in delivering human capital management solutions to various organizations. This includes the implementation and administration of employee benefits (health, wealth, and leaves benefits) solutions. It allows participants to access their solutions digitally, including through a mobile application on Alight Worklife, its intuitive, cloud-based employee engagement platform. Through Alight Worklife, the Company provides an enterprise level, integrated offering designed to drive better outcomes for organizations and individuals. Its primary business, Employer Solutions, is driven by its Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial wellbeing, leave of absence management and retiree healthcare. The Company also has Sword Health, which is an AI care platform that delivers clinical-grade care across various health conditions.

AI analysis of Alight Inc (ALIT)

hold

Alight Inc is not a strong buy at the moment due to its declining revenue and profitability metrics, despite a recent earnings beat. The current price is $14.02, and the forward P/E ratio is 1.32, indicating potential undervaluation, but the overall sentiment is cautious with a 62.71% year-to-date decline. The main risk is the significant revenue decline of 3.2% year-over-year in Q2 2026, which raises concerns about future growth.

Valuation Metrics

The current forward P/E ratio for Alight Inc (ALIT) is 1.32, compared to its 5-year average forward P/E of 11.11.

Forward P/E

Undervalued
5Y Average P/E
11.11
Current P/E
1.32
Overvalued
16.21
Undervalued
6.02

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.96
Current EV/EBITDA
7.40
Overvalued
12.24
Undervalued
5.68

Forward P/S

Undervalued
5Y Average P/S
1.17
Current P/S
0.26
Overvalued
1.65
Undervalued
0.69

Alphio AI Price Scenarios for ALIT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ALIT

$5.83

Scenario price

B

Base

Base · 50%ALIT

$4.91

Scenario price

B

Bear

Bear · 25%ALIT

$4.29

Scenario price

Whales holding ALIT

F

Fidelity National Financial, Inc.

+ HoldingALIT

-8.30%

3M Return

Events Timeline

2026-08-12 (ET)

09:30:00

Alight Appoints Three Senior Executives

2026-08-11 (ET)

09:30:00

Alight Adds eMed Platform to Partner Network

2026-08-04 (ET)

16:30:00

Company Reports Q2 Revenue of $511M

16:30:00

Alight Sees FY26 Revenue of $2.078B-$2.098B

16:30:00

Alight Sees Q3 Revenue of $469M-$479M, Consensus $501.79M

News

ALIT FAQ — answered by Alphio AI

Alight, Inc. is a cloud-based human capital technology and services provider. It is engaged in delivering human capital management solutions to various organizations. This includes the implementation and administration of employee benefits (health, wealth, and leaves benefits) solutions. It allows participants to access their solutions digitally, including through a mobile application on Alight Worklife, its intuitive, cloud-based employee engagement platform. Through Alight Worklife, the Company provides an enterprise level, integrated offering designed to drive better outcomes for organizations and individuals. Its primary business, Employer Solutions, is driven by its Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial wellbeing, leave of absence management and retiree healthcare. The Company also has Sword Health, which is an AI care platform that delivers clinical-grade care across various health conditions. It operates in the Technology sector (SERVICES-BUSINESS SERVICES, NEC industry).

Alight Inc is not a strong buy at the moment due to its declining revenue and profitability metrics, despite a recent earnings beat. The current price is $14.02, and the forward P/E ratio is 1.32, indicating potential undervaluation, but the overall sentiment is cautious with a 62.71% year-to-date decline. The main risk is the significant revenue decline of 3.2% year-over-year in Q2 2026, which raises concerns about future growth.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started